Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis

BACKGROUND: Therapeutic efficacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potentially preclude/pre-empt the detection of subsequent recrudescence of persistent, sub-microscopic primary infections. M...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612160/
https://www.ncbi.nlm.nih.gov/pubmed/31277713
http://dx.doi.org/10.1186/s12936-019-2837-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612160/
https://www.ncbi.nlm.nih.gov/pubmed/31277713
http://dx.doi.org/10.1186/s12936-019-2837-4

Ejemplares similares